Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.
Novo Nordisk said Thursday that it plans to eventually halt all of its human insulin pen production globally, ...
Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
Weight loss drugs are incredibly sought-after, but they’re also often difficult to obtain due to limited insurance coverage ...
A doctor and honorary researcher at the University of Exeter is leading a campaign to make reusable insulin pens the standard ...
Counterfeit Ozempic pens, which appear to be relabelled insulin pens, have been detected in Australia and have caused a ...
It also captures information including insulin brand, insulin dose measurement, injection date and time, and the temperature of the insulin pen at the time of injection, all of which are viewable ...
We take a look at some of the exciting diabetes research developments announced in October, and what the findings could mean for people living with or affected by diabetes.
Insulcloud today announced its strategic expansion into the U.S. following FDA clearance for its Insulclock CAP smart device.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback